Compare HODO & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HODO | CNSP |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 7.3M |
| IPO Year | 2025 | 2019 |
| Metric | HODO | CNSP |
|---|---|---|
| Price | $0.87 | $5.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.1M | 7.7K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $1.90 |
| 52 Week High | $2.52 | $10.59 |
| Indicator | HODO | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 20.09 | 51.29 |
| Support Level | $0.85 | $4.54 |
| Resistance Level | $1.39 | $5.53 |
| Average True Range (ATR) | 0.30 | 0.34 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 29.29 | 35.25 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.